ICU Medical, Inc.
ICUI
$133.31
$2.001.52%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.16B | 2.23B | 2.32B | 2.37B | 2.42B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.16B | 2.23B | 2.32B | 2.37B | 2.42B |
| Cost of Revenue | 1.34B | 1.41B | 1.47B | 1.52B | 1.57B |
| Gross Profit | 818.16M | 822.04M | 846.31M | 850.28M | 849.65M |
| SG&A Expenses | 622.54M | 625.21M | 628.25M | 638.18M | 638.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.05B | 2.12B | 2.19B | 2.25B | 2.30B |
| Operating Income | 110.13M | 109.33M | 129.30M | 123.56M | 121.25M |
| Income Before Tax | 9.49M | 3.17M | 29.77M | 15.90M | -40.15M |
| Income Tax Expenses | -36.85M | 2.44M | 37.14M | 52.85M | 53.54M |
| Earnings from Continuing Operations | 46.34 | 0.73 | -7.36 | -36.95 | -93.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.34M | 732.00K | -7.36M | -36.95M | -93.69M |
| EBIT | 110.13M | 109.33M | 129.30M | 123.56M | 121.25M |
| EBITDA | 311.45M | 310.08M | 332.21M | 331.34M | 334.68M |
| EPS Basic | 1.88 | 0.03 | -0.31 | -1.52 | -3.83 |
| Normalized Basic EPS | 0.90 | 0.74 | 1.09 | 0.77 | 0.42 |
| EPS Diluted | 1.85 | 0.02 | -0.32 | -1.53 | -3.84 |
| Normalized Diluted EPS | 0.90 | 0.74 | 1.08 | 0.77 | 0.42 |
| Average Basic Shares Outstanding | 98.78M | 98.56M | 98.36M | 98.11M | 97.86M |
| Average Diluted Shares Outstanding | 99.26M | 98.62M | 98.43M | 98.18M | 97.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |